Literature DB >> 10598689

Automated metabolic profiling and interpretation of GC/MS data for organic acidemia screening: a personal computer-based system.

M Kimura1, T Yamamoto, S Yamaguchi.   

Abstract

We have developed a personal computer-based system designed for automated metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry (GC/MS) and data interpretation for organic acidemia screening. For the automated profiling, we compiled retention indices, two target ions and their intensity ratio for 126 urinary metabolites. Metabolites above the cut-off values were flagged as abnormal compounds. The data interpretation was based on combination of the flagged metabolites. Diagnostic or index metabolites were categorized into three groups, "AND," "OR" and "NO," and compiled for each disorder to improve the specificity of the diagnosis. Groups "AND" and "OR" comprised essential and optional compounds, respectively, which and both to reach a specific diagnosis. Group "NO" comprised metabolites that must be absent to make a definite diagnosis. We tested this system by analyzing urine specimens from 48 patients previously diagnosed as having organic acidemias. In all cases, the diagnostic metabolites were identified and each correct diagnosis could be found among the possible diseases suggested by the system. Hence, with this simplified automated system, more people will be able to participate extensively in any screening programs using GC/MS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598689     DOI: 10.1620/tjem.188.317

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  15 in total

Review 1.  Metabolomics--the link between genotypes and phenotypes.

Authors:  Oliver Fiehn
Journal:  Plant Mol Biol       Date:  2002-01       Impact factor: 4.076

2.  Three Japanese Patients with Beta-Ketothiolase Deficiency Who Share a Mutation, c.431A>C (H144P) in ACAT1 : Subtle Abnormality in Urinary Organic Acid Analysis and Blood Acylcarnitine Analysis Using Tandem Mass Spectrometry.

Authors:  Toshiyuki Fukao; Shinsuke Maruyama; Toshihiro Ohura; Yuki Hasegawa; Mitsuo Toyoshima; Antti M Haapalainen; Naomi Kuwada; Mari Imamura; Isao Yuasa; Rik K Wierenga; Seiji Yamaguchi; Naomi Kondo
Journal:  JIMD Rep       Date:  2011-09-06

3.  Eight novel mutations of CBS gene in nine Chinese patients with classical homocystinuria.

Authors:  Dong-Xiao Li; Xi-Yuan Li; Hui Dong; Yu-Peng Liu; Yuan Ding; Jin-Qing Song; Ying Jin; Yao Zhang; Qiao Wang; Yan-Ling Yang
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

4.  The mitochondrial acetoacetyl-CoA thiolase (T2) deficiency in Japanese patients: urinary organic acid and blood acylcarnitine profiles under stable conditions have subtle abnormalities in T2-deficient patients with some residual T2 activity.

Authors:  T Fukao; G X Zhang; N Sakura; T Kubo; H Yamaga; A Hazama; Y Kohno; N Matsuo; M Kondo; S Yamaguchi; Y Shigematsu; N Kondo
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  Diagnosis, treatment, follow-up and gene mutation analysis in four Chinese children with biotinidase deficiency.

Authors:  J Ye; T Wang; L S Han; W J Qiu; H W Zhang; Y F Zhang; X L Gao; Y Wang; X F Gu
Journal:  J Inherit Metab Dis       Date:  2009-08-29       Impact factor: 4.982

6.  Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis.

Authors:  Daiju Oba; Shin-Ichi Inoue; Sachiko Miyagawa-Tomita; Yasumi Nakashima; Tetsuya Niihori; Seiji Yamaguchi; Yoichi Matsubara; Yoko Aoki
Journal:  EBioMedicine       Date:  2017-12-06       Impact factor: 8.143

7.  Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.

Authors:  Naoaki Shibata; Yuki Hasegawa; Kenji Yamada; Hironori Kobayashi; Jamiyan Purevsuren; Yanling Yang; Vu Chi Dung; Nguyen Ngoc Khanh; Ishwar C Verma; Sunita Bijarnia-Mahay; Dong Hwan Lee; Dau-Ming Niu; Georg F Hoffmann; Yosuke Shigematsu; Toshiyuki Fukao; Seiji Fukuda; Takeshi Taketani; Seiji Yamaguchi
Journal:  Mol Genet Metab Rep       Date:  2018-05-21

8.  A Japanese case of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency who presented with severe metabolic acidosis and fatty liver without hypoglycemia.

Authors:  Tomoko Lee; Yuichi Takami; Kenji Yamada; Hironori Kobayashi; Yuki Hasegawa; Hideo Sasai; Hiroki Otsuka; Yasuhiro Takeshima; Toshiyuki Fukao
Journal:  JIMD Rep       Date:  2019-06-03

9.  Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases.

Authors:  Ruxuan He; Ruo Mo; Ming Shen; Lulu Kang; Jinqing Song; Yi Liu; Zhehui Chen; Hongwu Zhang; Hongxin Yao; Yupeng Liu; Yao Zhang; Hui Dong; Ying Jin; Mengqiu Li; Jiong Qin; Hong Zheng; Yongxing Chen; Dongxiao Li; Haiyan Wei; Xiyuan Li; Huifeng Zhang; Min Huang; Chunyan Zhang; Yuwu Jiang; Desheng Liang; Yaping Tian; Yanling Yang
Journal:  Orphanet J Rare Dis       Date:  2020-08-03       Impact factor: 4.123

10.  Japanese patients with mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: In vitro functional analysis of five novel HMGCS2 mutations.

Authors:  Yasuhiko Ago; Hiroki Otsuka; Hideo Sasai; Elsayed Abdelkreem; Mina Nakama; Yuka Aoyama; Hideki Matsumoto; Ryoji Fujiki; Osamu Ohara; Kazumasa Akiyama; Kaori Fukui; Yoriko Watanabe; Yoko Nakajima; Hidenori Ohnishi; Tetsuya Ito; Toshiyuki Fukao
Journal:  Exp Ther Med       Date:  2020-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.